Neville Mehenti

Neville Mehenti is Senior Director of Global Commercial Product Strategy, and has been at Gilead Sciences since 214, where he conducts strategic planning for the Oncology pipeline portfolio and diligence assessments for business development opportunities. Prior to Gilead, Neville was a strategy consultant at L.E.K. Consulting for 7 years, where he advised life sciences companies, including IVD suppliers and LDT developers, on strategy and transactions. Prior to consulting, Neville received his Ph.D. in Chemical Engineering from Stanford University.